• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在活动性 KSHV+多中心 Castleman 病期间循环的 KSHV 感染的病毒母细胞的特征。

Characteristics of circulating KSHV-infected viroblasts during active KSHV+ multicentric Castleman disease.

机构信息

INSERM U976 HIPI, équipe INSIGHT, Institut de Recherche Saint-Louis, Université Paris Cité, Paris, France.

Department of Clinical Immunology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France.

出版信息

Blood Adv. 2023 May 9;7(9):1682-1691. doi: 10.1182/bloodadvances.2022008456.

DOI:10.1182/bloodadvances.2022008456
PMID:36508281
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10182301/
Abstract

Kaposi sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8-associated multicentric Castleman disease (MCD) is a polyclonal B-cell lymphoproliferative disorder that mainly occurs in immunocompromised hosts. The diagnosis relies on lymph node biopsy demonstrating KSHV-infected cells located in the mantle zone with a marked interfollicular plasma cell infiltration. Infected cells are large cells positive for immunoglobulin M (IgM), λ light chain, and CD38, described initially as infected plasmablasts. We show that IgM+λ+CD38high cells were also detectable in the peripheral blood of 14 out of 18 (78%) patients with active KSHV-MCD and absent in 40 controls. Using immunofluorescence and flow-fluorescence in situ hybridization, we demonstrate that these cells are KSHV infected and express both latent and lytic KSHV transcripts. These KSHV-infected viroblasts (KIVs) harbor a distinct phenotype compared with conventional plasmablasts. We also identified several putative mechanisms of immune escape used by KSHV, because KIVs displayed an overall decrease of costimulatory molecules, with a remarkable lack of CD40 expression and are interleukin-10-producing cells. The identification of this specific and easily accessible KSHV+ circulating population brings new elements to the understanding of KSHV-MCD but also raises new questions that need to be clarified.

摘要

卡波西肉瘤相关疱疹病毒(KSHV)/人类疱疹病毒 8 相关多中心 Castleman 病(MCD)是一种多克隆 B 细胞淋巴增生性疾病,主要发生在免疫功能低下的宿主中。诊断依赖于淋巴结活检,显示位于套区的 KSHV 感染细胞,伴有明显的滤泡间浆细胞浸润。感染细胞为大细胞,免疫球蛋白 M(IgM)、λ 轻链和 CD38 阳性,最初描述为感染的浆母细胞。我们表明,在 18 名活动性 KSHV-MCD 患者中的 14 名(78%)患者的外周血中也可检测到 IgM+λ+CD38high 细胞,而在 40 名对照中则不存在。通过免疫荧光和流式荧光原位杂交,我们证明这些细胞被 KSHV 感染,并表达潜伏和裂解的 KSHV 转录本。与传统的浆母细胞相比,这些被 KSHV 感染的病毒母细胞(KIV)具有独特的表型。我们还确定了 KSHV 用于免疫逃避的几种潜在机制,因为 KIV 显示出共刺激分子的总体减少,CD40 表达明显缺乏,并且是白细胞介素-10 产生细胞。这种特定且易于获得的 KSHV+循环群体的鉴定为理解 KSHV-MCD 带来了新的元素,但也提出了需要澄清的新问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/003e/10182301/71c16a5433fe/BLOODA_ADV-2022-008456-gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/003e/10182301/926e3015aa10/BLOODA_ADV-2022-008456-fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/003e/10182301/0a8400511b41/BLOODA_ADV-2022-008456-gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/003e/10182301/c197eaa07923/BLOODA_ADV-2022-008456-gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/003e/10182301/4f4c19d9c750/BLOODA_ADV-2022-008456-gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/003e/10182301/eaf638c8ec77/BLOODA_ADV-2022-008456-gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/003e/10182301/71c16a5433fe/BLOODA_ADV-2022-008456-gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/003e/10182301/926e3015aa10/BLOODA_ADV-2022-008456-fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/003e/10182301/0a8400511b41/BLOODA_ADV-2022-008456-gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/003e/10182301/c197eaa07923/BLOODA_ADV-2022-008456-gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/003e/10182301/4f4c19d9c750/BLOODA_ADV-2022-008456-gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/003e/10182301/eaf638c8ec77/BLOODA_ADV-2022-008456-gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/003e/10182301/71c16a5433fe/BLOODA_ADV-2022-008456-gr5.jpg

相似文献

1
Characteristics of circulating KSHV-infected viroblasts during active KSHV+ multicentric Castleman disease.在活动性 KSHV+多中心 Castleman 病期间循环的 KSHV 感染的病毒母细胞的特征。
Blood Adv. 2023 May 9;7(9):1682-1691. doi: 10.1182/bloodadvances.2022008456.
2
Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders.卡波西肉瘤相关疱疹病毒在卡斯特曼病及相关淋巴增殖性疾病中感染单型(IgM λ)但多克隆的幼稚B细胞。
Blood. 2001 Apr 1;97(7):2130-6. doi: 10.1182/blood.v97.7.2130.
3
Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral Interleukin-6 by X-Box Binding Protein 1.X盒结合蛋白1对卡波西肉瘤相关疱疹病毒编码的病毒白细胞介素-6的诱导作用
J Virol. 2015 Oct 21;90(1):368-78. doi: 10.1128/JVI.01192-15. Print 2016 Jan 1.
4
A novel approach for characterization of KSHV-associated multicentric Castleman disease from effusions.一种用于从积液中表征与 KSHV 相关的多中心 Castleman 病的新方法。
Br J Haematol. 2023 Feb;200(4):462-475. doi: 10.1111/bjh.18518. Epub 2022 Oct 20.
5
Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV-MCD) and the KSHV Inflammatory Cytokine Syndrome.卡波西肉瘤疱疹病毒裂解激活的临床表现:多中心性Castleman病(KSHV-MCD)和KSHV炎性细胞因子综合征。
Front Microbiol. 2012 Mar 2;3:73. doi: 10.3389/fmicb.2012.00073. eCollection 2012.
6
Immunophenotypic analysis of the Kaposi sarcoma herpesvirus (KSHV; HHV-8)-infected B cells in HIV+ multicentric Castleman disease (MCD).对感染卡波西肉瘤疱疹病毒(KSHV;HHV - 8)的HIV阳性多中心Castleman病(MCD)中的B细胞进行免疫表型分析。
Histopathology. 2008 Nov;53(5):513-24. doi: 10.1111/j.1365-2559.2008.03144.x.
7
High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease.艾滋病病毒感染和多中心Castleman病患者中卡波西肉瘤相关疱疹病毒相关非霍奇金淋巴瘤的高发病率。
Blood. 2002 Apr 1;99(7):2331-6. doi: 10.1182/blood.v99.7.2331.
8
Bone marrow findings in HIV-positive patients with Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.HIV 阳性患者卡波西肉瘤疱疹病毒相关多中心 Castleman 病的骨髓表现。
Am J Clin Pathol. 2013 May;139(5):651-61. doi: 10.1309/AJCPKGF7U8AWQBVG.
9
Kaposi sarcoma herpes virus-associated hemophagocytic syndrome complicated by multicentric castleman disease and kaposi sarcoma in a HIV-negative immunocompetent patient: an autopsy case.HIV 阴性免疫功能正常患者的卡波西肉瘤疱疹病毒相关噬血细胞性综合征并发多中心 Castleman 病和卡波西肉瘤:一例尸检病例。
J Korean Med Sci. 2009 Oct;24(5):970-4. doi: 10.3346/jkms.2009.24.5.970. Epub 2009 Sep 24.
10
Human herpesvirus 8+ polyclonal IgMλ B-cell lymphocytosis mimicking plasmablastic leukemia/lymphoma in HIV-infected patients.人类疱疹病毒 8 型+多克隆 IgMλ B 细胞淋巴增生症酷似 HIV 感染患者的浆母细胞白血病/淋巴瘤。
Eur J Haematol. 2013 Dec;91(6):497-503. doi: 10.1111/ejh.12191. Epub 2013 Sep 18.

引用本文的文献

1
Lymphoproliferations in People Living with HIV: Oncogenic Pathways, Diagnostic Challenges, and New Therapeutic Opportunities.HIV感染者的淋巴细胞增殖:致癌途径、诊断挑战及新的治疗机遇
Cancers (Basel). 2025 Jun 22;17(13):2088. doi: 10.3390/cancers17132088.
2
Modern Approach to Manage Patients With Kaposi Sarcoma.管理卡波西肉瘤患者的现代方法。
J Med Virol. 2025 Mar;97(3):e70294. doi: 10.1002/jmv.70294.
3
When cytokine storms collide: understanding hemophagocytic lymphohistiocytosis in human herpesvirus 8/Kaposi sarcoma herpesvirus-associated multicentric Castleman disease among people with HIV.

本文引用的文献

1
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.COVID-19 重症患者的白细胞介素 6 受体拮抗剂。
N Engl J Med. 2021 Apr 22;384(16):1491-1502. doi: 10.1056/NEJMoa2100433. Epub 2021 Feb 25.
2
Analysis of KSHV B lymphocyte lineage tropism in human tonsil reveals efficient infection of CD138+ plasma cells.分析人类扁桃体组织中 KSHV 对 B 淋巴细胞谱系的嗜性,揭示 CD138+浆细胞的高效感染。
PLoS Pathog. 2020 Oct 19;16(10):e1008968. doi: 10.1371/journal.ppat.1008968. eCollection 2020 Oct.
3
Rapid identification and characterization of infected cells in blood during chronic active Epstein-Barr virus infection.
当细胞因子风暴相遇时:了解人类疱疹病毒8型/卡波西肉瘤疱疹病毒相关多中心Castleman病在HIV感染者中的噬血细胞性淋巴组织细胞增生症。
AIDS. 2025 Apr 1;39(5):618-620. doi: 10.1097/QAD.0000000000004117. Epub 2025 Mar 13.
4
Primary Effusion Lymphoma Prognostic Score (PEL-PS): A Validated International Prognostic Score in HIV-Associated Primary Effusion Lymphoma.原发性渗出性淋巴瘤预后评分(PEL-PS):一种经验证的HIV相关原发性渗出性淋巴瘤国际预后评分。
Am J Hematol. 2025 Mar;100(3):393-401. doi: 10.1002/ajh.27580. Epub 2025 Jan 15.
5
HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus.人类免疫缺陷病毒相关癌症和卡波西肉瘤疱疹病毒与 Epstein-Barr 病毒引起的淋巴组织增生性疾病。
Clin Microbiol Rev. 2024 Sep 12;37(3):e0002223. doi: 10.1128/cmr.00022-23. Epub 2024 Jun 20.
6
Mechanism of herpesvirus UL24 protein regulating viral immune escape and virulence.疱疹病毒UL24蛋白调节病毒免疫逃逸和毒力的机制。
Front Microbiol. 2023 Sep 22;14:1268429. doi: 10.3389/fmicb.2023.1268429. eCollection 2023.
7
Clinical management of Kaposi sarcoma herpesvirus-associated diseases: an update on disease manifestations and treatment strategies.卡波西肉瘤疱疹病毒相关疾病的临床管理:疾病表现和治疗策略的更新。
Expert Rev Anti Infect Ther. 2023 Jul-Dec;21(9):929-941. doi: 10.1080/14787210.2023.2247161. Epub 2023 Aug 15.
8
Higher rate of progression in HIV- than in HIV+ patients after rituximab for HHV8+ multicentric Castleman disease.利妥昔单抗治疗 HHV8+多中心 Castleman 病后,HIV-患者比 HIV+患者进展更快。
Blood Adv. 2023 Sep 26;7(18):5663-5669. doi: 10.1182/bloodadvances.2023010316.
在慢性活动性 EBV 感染期间快速鉴定和特征化血液中的感染细胞。
J Exp Med. 2020 Nov 2;217(11). doi: 10.1084/jem.20192262.
4
Tocilizumab in patients with symptomatic Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.托珠单抗治疗有症状的卡波西肉瘤疱疹病毒相关多中心性Castleman病患者。
Blood. 2020 Jun 18;135(25):2316-2319. doi: 10.1182/blood.2019004602.
5
Signaling pathways involved in the T-cell-mediated immunity against Epstein-Barr virus: Lessons from genetic diseases.T 细胞介导的针对 Epstein-Barr 病毒免疫的信号通路:来自遗传疾病的启示。
Immunol Rev. 2019 Sep;291(1):174-189. doi: 10.1111/imr.12791.
6
Kaposi sarcoma-associated herpesvirus/human herpesvirus 8-associated lymphoproliferative disorders.卡波西肉瘤相关疱疹病毒/人类疱疹病毒 8 相关淋巴组织增生性疾病。
Blood. 2019 Mar 14;133(11):1186-1190. doi: 10.1182/blood-2018-11-852442. Epub 2019 Jan 4.
7
Functions of CD40 and Its Ligand, gp39 (CD40L).CD40及其配体gp39(CD40L)的功能。
Crit Rev Immunol. 2017;37(2-6):371-420. doi: 10.1615/CritRevImmunol.v37.i2-6.100.
8
The full spectrum of Castleman disease: 273 patients studied over 20 years.卡斯特曼病全谱:20年间研究的273例患者
Br J Haematol. 2018 Jan;180(2):206-216. doi: 10.1111/bjh.15019. Epub 2017 Nov 16.
9
The Antibody-Secreting Cell Response to Infection: Kinetics and Clinical Applications.针对感染的抗体分泌细胞反应:动力学与临床应用
Front Immunol. 2017 Jun 1;8:630. doi: 10.3389/fimmu.2017.00630. eCollection 2017.
10
iNKT and memory B-cell alterations in HHV-8 multicentric Castleman disease.HHV-8 多中心 Castleman 病中 iNKT 和记忆 B 细胞的改变。
Blood. 2017 Feb 16;129(7):855-865. doi: 10.1182/blood-2016-06-719716. Epub 2016 Nov 9.